Clinical Trials Directory

Trials / Completed

CompletedNCT02221167

Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes

Rx Milk: Donor Milk Supplementation to Increase Breastfeeding Duration & Exclusivity, a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Laura Kair · Academic / Other
Sex
All
Age
24 Hours – 48 Hours
Healthy volunteers
Not accepted

Summary

This study is a randomized controlled trial seeking to determine whether supplementing infants at risk for excessive neonatal weight loss with a small volume of human donor milk prophylactically in the first 1-3 days of life, before maternal mature milk production (before mom's milk "comes in") will decrease the incidence of formula use at 1 week and 1, 2, and 3 months of life and increase the rate of exclusive breastfeeding in this high-risk population. We hypothesize that supplementation of term infants who have lost greater than or equal to 5% birth weight by 36 hours of age with a small volume of donor breast milk following feeds, until mature milk production, will result in decreased supplemental formula use at 1 week and increased exclusive as well as any breastfeeding at 1 week and 1, 2, and 3 months. This study's specific aims are to compare the effectiveness of encouraging in-hospital exclusive breastfeeding with offering early small-volume donor milk supplementation in a population of infants at risk for excessive neonatal weight loss with goals of 1) decreasing the incidence of formula supplementation at 1 week of life and 2) improving breastfeeding duration.

Conditions

Interventions

TypeNameDescription
OTHERDonor Milkbreastfeeding plus 10 ml of donor milk by syringe after each breastfeeding until mother's milk "comes in."

Timeline

Start date
2014-07-01
Primary completion
2016-07-01
Completion
2016-09-01
First posted
2014-08-20
Last updated
2018-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02221167. Inclusion in this directory is not an endorsement.